Health care resource utilization and costs among patients with multiple myeloma with exposure to double-class or triple-class multiple myeloma treatments: A retrospective US claims database analysis-Reference-Cited by-同舟云学术

Health care resource utilization and costs among patients with multiple myeloma with exposure to double-class or triple-class multiple myeloma treatments: A retrospective US claims database analysis

Published:2023-08 Issue:8 Volume:29 Page:917-926
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Yang Joseph¹,Boytsov Natalie²,Carlson Josh J.¹,Barthold Douglas¹

Affiliation:

1. Department of Pharmacy, CHOICE Institute, University of Washington, Seattle.

2. GSK, Value Evidence and Outcomes, Collegeville, PA.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Reference22 articles.

1. Multiple myeloma: an overview of management

2. SEER. Cancer stat facts: Myeloma. National Cancer Institute. 2020. Accessed April 24, 2023. https://seer.cancer.gov/statfacts/html/mulmy.html

3. Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update

4. Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology

5. Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population;Oncology and Therapy;2024-08-04

2. Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies;Blood Advances;2024-06-14

3. Evolution of Pharmacological Treatments and Associated Costs for Multiple Myeloma in the Public Healthcare System of Catalonia: A Retrospective Observational Study;Cancers;2023-11-09